Hoffmann-La Roche Buys DeCypher Accelerator For Drug Discovery

INCLINE VILLAGE, Nev.--Time Logic here has sold a DeCypher ES-1920 computational bioinformatics accelerator to Hoffmann-La Roche, which "intends to use this powerful computer tool in the process of the discovery of new drugs to treat human diseases and conditions," according to the pharmaceutical company's Michael Braxenthaler. DeCypher uses unique search algorithms, accelerated to supercomputing speeds by an array of parallel processors, to rapidly search large DNA and protein sequence databases, according to Richard Offerdahl, the company's president and CEO.